Parvo preventative picks up speedElanco will acquire exclusive global rights to KindredBio’s KIND-030 monoclonal antibody December 29, 2020 The deaths of countless puppies might soon be prevented, thanks to a newly announced agreement. Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus (CPV). The global license includes an upfront payment of $500,000, as well as additional milestone payments based on successful completion of development targets, including efficacy, formulation, and manufacturing, Elanco says. “[This] announcement brings us a step closer to saving hundreds of thousands of dogs exposed to this deadly disease each year,” says KindredBio’s CEO, Richard Chin, MD. “We believe KIND-030 can transform the way parvovirus infections are treated and prevented.” Banfield Pet Hospital estimates there are approximately a quarter of a million parvo cases in the U.S. annually, according to Elanco. Additionally, the company says, BluePearl noted a 70 percent increase in cases at its hospitals amidst the COVID pandemic. At this time, there are no approved treatments for CPV, Elanco says. “With parvovirus on the rise, it’s more important than ever to bring a new treatment option to veterinarians for this devastating and deadly disease,” says Aaron Schacht, Elanco’s executive vice president of innovation, regulatory, and business development. “We’re excited to establish this important partnership with KindredBio to develop and commercialize this novel monoclonal antibody.” KIND-030 is currently being pursued for two indications in dogs: prophylactic therapy to prevent clinical signs of CPV infection and treatment of established parvovirus infection. Completion of an upcoming pivotal efficacy study for the therapeutic indication is expected in the first quarter of 2021, Elanco says. A study conducted by Kindred Biosciences earlier this year demonstrated 100 percent efficacy in the prevention of CPV, as well as a mortality benefit in the treated group. For more, click here.
SponsoredFeline urinary health—meet a simple solutionUrinary health is complicated, but the solution doesn’t have to be. Our products nutritionally support urinary tract and bladder health at any stage. + Recommend Today
Suggested Veterinary Products ULTRA 12040Hf Portable X-Ray UnitFeatures 40-120kV, in 1kV increments and with its ripple-free HFG system, you can shoot up to 120kV, 40mA with full logic control operation. It also provides high resolution imaging at lower...Double Head Probe Wireless Mini UltrasoundThis Ultrasound Probe consists of two heads (you can select convex, linear, micro-convex, transvaginal), and is suited for multiple applications at the same time – All while costing less than...
SponsoredThey love them soYou know pet owners want to make sure they’re protected everywhere they go. + Learn more